About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Cystic Fibrosis Therapeutics Market Size, Top Share, Forecast to 2030
Cystic Fibrosis Therapeutics Market

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration (Oral Drugs, Inhaled Drugs), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, Hospital Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRHI2700DR
Author : Debashree Bora
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Cystic Fibrosis Therapeutics Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    5. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Pancreatic Enzyme Supplements
          1. By Value
        3. Mucolytics
          1. By Value
        4. Bronchodilators
          1. By Value
        5. CFTR Modulators
          1. By Value
      2. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drugs
          1. By Value
        3. Inhaled Drugs
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail Pharmacies & Drug Stores
          1. By Value
        3. Online Pharmacies
          1. By Value
        4. Hospital Pharmacies
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    5. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Pancreatic Enzyme Supplements
          1. By Value
        3. Mucolytics
          1. By Value
        4. Bronchodilators
          1. By Value
        5. CFTR Modulators
          1. By Value
      2. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drugs
          1. By Value
        3. Inhaled Drugs
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail Pharmacies & Drug Stores
          1. By Value
        3. Online Pharmacies
          1. By Value
        4. Hospital Pharmacies
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    5. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Pancreatic Enzyme Supplements
          1. By Value
        3. Mucolytics
          1. By Value
        4. Bronchodilators
          1. By Value
        5. CFTR Modulators
          1. By Value
      2. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drugs
          1. By Value
        3. Inhaled Drugs
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail Pharmacies & Drug Stores
          1. By Value
        3. Online Pharmacies
          1. By Value
        4. Hospital Pharmacies
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    5. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Pancreatic Enzyme Supplements
          1. By Value
        3. Mucolytics
          1. By Value
        4. Bronchodilators
          1. By Value
        5. CFTR Modulators
          1. By Value
      2. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drugs
          1. By Value
        3. Inhaled Drugs
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail Pharmacies & Drug Stores
          1. By Value
        3. Online Pharmacies
          1. By Value
        4. Hospital Pharmacies
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Pancreatic Enzyme Supplements
        1. By Value
      3. Mucolytics
        1. By Value
      4. Bronchodilators
        1. By Value
      5. CFTR Modulators
        1. By Value
    3. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Oral Drugs
        1. By Value
      3. Inhaled Drugs
        1. By Value
    4. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Retail Pharmacies & Drug Stores
        1. By Value
      3. Online Pharmacies
        1. By Value
      4. Hospital Pharmacies
        1. By Value
    5. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Pancreatic Enzyme Supplements
          1. By Value
        3. Mucolytics
          1. By Value
        4. Bronchodilators
          1. By Value
        5. CFTR Modulators
          1. By Value
      2. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Oral Drugs
          1. By Value
        3. Inhaled Drugs
          1. By Value
      3. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Retail Pharmacies & Drug Stores
          1. By Value
        3. Online Pharmacies
          1. By Value
        4. Hospital Pharmacies
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Cystic Fibrosis Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Vertex Pharmaceutical Incorporated
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Roche
    3. Nestle Health Science
    4. AbbVie
    5. Viatris Inc.
    6. Horizon Therapeutic Plc.
    7. Gilead Sciences
    8. Chiesi Farmacrutici
    9. Pharmaxis Ltd.
    10. Teva Pharmaceuticals
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Microbiome Therapeutics Market Size The global microbiome therapeutics market size was valued at USD 591.85 million in 2024 and is expected to grow from USD 738.63 million in 2025 to USD 4346.54 million by 2033, growing at a CAGR
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.